Favipiravir for Treatment of Outpatients With Asymptomatic or Uncomplicated Coronavirus Disease 2019: A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial.

Autor: Holubar M; Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, California, USA., Subramanian A; Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, California, USA., Purington N; Quantitative Sciences Unit, Division of Biomedical Informatics Research, Department of Medicine, Stanford University, Palo Alto, California, USA., Hedlin H; Quantitative Sciences Unit, Division of Biomedical Informatics Research, Department of Medicine, Stanford University, Palo Alto, California, USA., Bunning B; Quantitative Sciences Unit, Division of Biomedical Informatics Research, Department of Medicine, Stanford University, Palo Alto, California, USA., Walter KS; Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, California, USA., Bonilla H; Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, California, USA., Boumis A; Stanford Center for Clinical Research, Stanford University, Stanford, California, USA., Chen M; Stanford Solutions, Stanford University School of Medicine, Stanford, California, USA., Clinton K; Stanford Center for Clinical Research, Stanford University, Stanford, California, USA., Dewhurst L; Stanford Center for Clinical Research, Stanford University, Stanford, California, USA., Epstein C; Carol L. Epstein MD Consulting LLC, Wellington, Florida, USA., Jagannathan P; Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, California, USA.; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California, USA., Kaszynski RH; Stanford Solutions, Stanford University School of Medicine, Stanford, California, USA., Panu L; Stanford Center for Clinical Research, Stanford University, Stanford, California, USA., Parsonnet J; Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, California, USA.; Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, California, USA., Ponder EL; Stanford ChEM-H, Stanford University, Stanford, California, USA., Quintero O; Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, California, USA., Sefton E; Stanford ChEM-H, Stanford University, Stanford, California, USA., Singh U; Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, California, USA.; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California, USA., Soberanis L; Stanford Center for Clinical Research, Stanford University, Stanford, California, USA., Truong H; Mariner Advanced Pharmacy Corporation, San Mateo, California, USA., Andrews JR; Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, California, USA., Desai M; Quantitative Sciences Unit, Division of Biomedical Informatics Research, Department of Medicine, Stanford University, Palo Alto, California, USA., Khosla C; Stanford ChEM-H, Stanford University, Stanford, California, USA.; Departments of Chemistry and Chemical Engineering, Stanford University, Stanford, California, USA., Maldonado Y; Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, California, USA.; Department of Pediatrics, Stanford University School of Medicine, Stanford, California, USA.

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2022 Nov 30; Vol. 75 (11), pp. 1883-1892.

Catalysts for hydroprocessing of Maya heavy crude

Autor: Maity, S.K, Ancheyta, J, Soberanis, L, Alonso, F

Publikováno v: In Applied Catalysis A, General 2003 253(1):125-134

Alumina–titania binary mixed oxide used as support of catalysts for hydrotreating of Maya heavy crude

Autor: Maity, S.K., Ancheyta, J., Soberanis, L., Alonso, F., Llanos, M.E.

Publikováno v: In Applied Catalysis A, General 2003 244(1):141-153

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.